BMRA Financials

Income Statement
MetricQ1 2027Q4 2026Q3 2026Q2 2026Q1 2026
Revenue
1.3M
+44.6%
875.0K
-11.3%
987.0K
-18.4%
1.2M
-12.3%
1.4M
Cost of Revenue
1.2M
+22.8%
946.0K
-8.2%
1.0M
-11.0%
1.2M
+21.2%
956.0K
Gross Profit
103.0K
+245.1%
-71000
-61.4%
-44000
-186.3%
51.0K
-88.0%
424.0K
Operating Expenses
1.3M
-9.0%
1.5M
+16.6%
1.3M
-11.9%
1.4M
-7.7%
1.5M
R&D
206.0K
+0.5%
205.0K
+15.2%
178.0K
-7.8%
193.0K
-9.0%
212.0K
SG&A
1.1M
-10.6%
1.3M
+16.8%
1.1M
-12.6%
1.2M
-7.4%
1.3M
Operating Income
-1227000
+20.0%
-1533000
-18.1%
-1298000
+5.5%
-1373000
-22.8%
-1118000
EBITDA
-1212000
+20.1%
-1516000
-18.6%
-1278000
+5.5%
-1353000
-23.2%
-1098000
Net Income
-1232000
-7.6%
-1145000
+12.7%
-1312000
+0.6%
-1320000
-66100.0%
2.0K
EPS (Basic)
$-0.37
+0.0%
$-0.37
+15.9%
$-0.44
+2.2%
$-0.45
$0.00
EPS (Diluted)
$-0.37
+0.0%
$-0.37
+15.9%
$-0.44
+2.2%
$-0.45
$0.00
Shares (Diluted)
3.3M
+6.2%
3.1M
+3.1%
3.0M
+3.5%
2.9M
+10.2%
2.6M
BIOMERICA (BMRA) โ€” Financials